KANSURE 260 MG INJ. VIAL.

About

KANSURE 260 MG INJ. VIAL. contains an antineoplastic agent, a critical component in the fight against various cancers. This medication is designed to interfere with the growth and spread of cancer cells through specific mechanisms, which may include disrupting DNA synthesis, inhibiting cell division, or inducing programmed cell death (apoptosis). As a cytotoxic agent, it targets rapidly dividing cells, a characteristic feature of malignant tumors. Its efficacy often lies in its ability to reduce tumor burden, prevent metastasis, and improve patient outcomes, either as a standalone therapy or, more commonly, as part of a multi-drug chemotherapy regimen. The precise mechanism of action depends on the specific drug class, but the overarching goal is to selectively destroy cancer cells while minimizing harm to healthy tissues. Careful administration and vigilant monitoring for adverse effects are paramount to ensure patient safety and optimize therapeutic benefits.

Uses

• Treatment of various solid tumors
• Management of hematologic malignancies
• Used in metastatic disease
• Adjuvant therapy after surgery

Directions For Use

Administered intravenously by a qualified healthcare professional. Dosage and frequency are determined by the specific cancer type, patient's condition, and treatment protocol.

Benefits

• Effective against a range of cancers
• Can be used in combination therapy
• Helps reduce tumor burden
• Improves patient outcomes and survival
• Provides palliative relief for advanced disease
• Offers a crucial treatment option for aggressive cancers

Side Effects

• Myelosuppression (low blood counts)
• Nausea and vomiting
• Fatigue and malaise
• Alopecia (hair loss)
• Mucositis or stomatitis
• Peripheral neuropathy
• Hypersensitivity reactions
• Diarrhea or constipation
• Increased risk of infections
• Liver enzyme elevations
• Fluid retention or edema
• Anorexia and weight loss

Safety Measures

• Alcohol - Avoid alcohol consumption during treatment as it may exacerbate liver toxicity and general side effects of chemotherapy.
• Pregnancy - Contraindicated. This antineoplastic agent is teratogenic and can cause severe fetal harm. Effective contraception is mandatory.
• Breastfeeding - Contraindicated. The drug is excreted in breast milk and can cause serious adverse effects in the infant.
• Liver - Use with caution in patients with hepatic impairment. Dose adjustments may be necessary based on liver function tests.
• Kidney - Use with caution in patients with renal impairment. Monitor renal function tests regularly during treatment.
• Lung - Monitor for pulmonary adverse events, including pneumonitis or fibrosis, especially if respiratory symptoms develop.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.